BioCentury | Jun 26, 2020
Distillery Therapeutics
MAP3K7, IL18R1 as targets in obesity-related cerebrovascular dysfunction
...kinase kinase kinase 7 (MAP3K7; TAK1); interleukin-18 receptor 1 (IL18R1; CD218a; IL18RA; IL-18Rα); endothelial cell nitric oxide synthase...